Kadima High Tech

Venture Capital Active Israel
Last updated 2026-06-18
Portfolio
3
in our dataset
Rounds participated
3
Rounds led
1
Rounds' value
$47.0M
total disclosed, rounds participated
Stages

Portfolio · 3

Investment activity

2 portfolio exits on record.

Portfolio by sector

Health Tech & Life Sciences2
Business Software1

Q&A

What is Kadima High Tech's primary investment focus by sector?
Kadima High Tech has a notable concentration in Health Tech & Life Sciences, with two of its portfolio companies operating in this sector. They also have one investment in Business Software.
Which of Kadima High Tech's portfolio companies has gone public?
VBL Therapeutics, a company focused on targeted therapies for immune-inflammatory diseases, went public on NASDAQ in October 2014 with a valuation of $120M.
Can you name another public exit for Kadima High Tech?
Rosetta Genomics, a company specializing in microRNA-based diagnostic tests, also went public on NASDAQ in February 2007.
What is the most recent exit for Kadima High Tech?
Kadima High Tech's most recent exit was VBL Therapeutics, which went public on NASDAQ in October 2014.
What is the total capital raised by VBL Therapeutics, a Kadima High Tech portfolio company?
VBL Therapeutics raised a total of $109.77M before going public.
What is the earliest recorded investment year for Kadima High Tech?
Kadima High Tech's earliest recorded investment year is 2001.